Dr. Beau Raines
C.E.O., President
"After 17 years of cancer research,
I have never seen anything like this.
This is Nobel Prize stuff."
Robert Ainbinder,CFO
Robert Ainbinder, serves as the
Company's Chief Financial Offer
Scientific Consultants
Dr. Mark C. Willingham
Director of Research
Professor of Pathology,
Section Head, Tumor Biology
Wake Forest University